Viewing Study NCT02409667


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-04-17 @ 11:59 PM
Study NCT ID: NCT02409667
Status: COMPLETED
Last Update Posted: 2019-05-13
First Post: 2015-03-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Plaque Psoriasis Efficacy and Safety With Secukinumab
Sponsor: Novartis Pharmaceuticals
Organization: